Neurobiogen, applied for FDA ODD (Orphan Drug Designation) for 'Acute Spinal Cord Injury' treatment, 'KDS2010'
World's first investigation into the cause of stroke sequelae... Clinical trial of the treatment will begin next year
Uncover the secret of stroke that remains symptoms even after treatment... “Confirmed the efficacy of technology transfer new drug”
NEUROBIOGEN, a new drug candidate,'KDS2010' registered for a patent in China
NEUROBIOGEN completes patent registration in the US and Canada for new drug development substance
NEUROBIOGEN, start developing new obesity drug 'KDS2010'
IBS launches joint research on new drug for Alzheimer treatment Study on the mechanism of 'Seremabi', a candidate drug for treatment of Alzheimer, Parkinson, and Obesity
New Hope for Dementia Treatment and Central Nervous System Disease Blockbuster Candidate Overcoming the Limits of Existing Drugs